BBCMF (Lir Life Sciences) Scaled Net Operating Assets: 0.09 (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Scaled Net Operating Assets?

Lir Life Sciences BBCMF -80.00% 15 Scaled Net Operating Assets is 0.09 as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lir Life Sciences's operating assets for the quarter that ended in Jan. 2026 was $0.16 Mil. Lir Life Sciences's operating liabilities for the quarter that ended in Jan. 2026 was $0.06 Mil. Lir Life Sciences's Total Assets for the quarter that ended in Oct. 2025 was $1.11 Mil. Therefore, Lir Life Sciences's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2026 was 0.09.

Lir Life Sciences Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Scaled Net Operating Assets Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Scaled Net Operating Assets
-0.13 -0.97

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Scaled Net Operating Assets Get a 7-Day Free Trial 0.00 0.00 -2.16 0.15 0.09

BBCMF vs VRTX, REGN, ALNY: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Lir Life Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lir Life Sciences Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lir Life Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Lir Life Sciences's Scaled Net Operating Assets falls into.


BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lir Life Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Apr. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Apr. 2025 )
=(Operating Assets (A: Apr. 2025 )-Operating Liabilities (A: Apr. 2025 ))/Total Assets (A: Apr. 2024 )
=(0-0.145)/0.15
=-0.97

where

Operating Assets(A: Apr. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.087 - 0.087
=0

Operating Liabilities(A: Apr. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.145 - 0 - 0
=0.145

Lir Life Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jan. 2026 )
=(Operating Assets (Q: Jan. 2026 )-Operating Liabilities (Q: Jan. 2026 ))/Total Assets (Q: Oct. 2025 )
=(0.16-0.057)/1.107
=0.09

where

Operating Assets(Q: Jan. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.829 - 0.669
=0.16

Operating Liabilities(Q: Jan. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.057 - 0 - 0
=0.057

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.09 mean?
Lir Life Sciences (BBCMF) has a Scaled Net Operating Assets of 0.09 as of Jan. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Scaled Net Operating Assets too high?
Lir Life Sciences' current Scaled Net Operating Assets is 0.09. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Scaled Net Operating Assets compare to VRTX and REGN?
Lir Life Sciences' Scaled Net Operating Assets of 0.09 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Scaled Net Operating Assets is 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Scaled Net Operating Assets of 0.09. The current Scaled Net Operating Assets is 0.09. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Scaled Net Operating Assets is 0.09 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price